Palla, Adelaida R. https://orcid.org/0000-0003-2695-9335
Hilgendorf, Keren I. https://orcid.org/0000-0001-8377-8384
Yang, Ann V.
Kerr, Jaclyn P.
Hinken, Aaron C.
Demeter, Janos https://orcid.org/0000-0002-7301-8055
Kraft, Peggy
Mooney, Nancie A.
Yucel, Nora
Burns, David M.
Wang, Yu Xin
Jackson, Peter K. https://orcid.org/0000-0002-1742-2539
Blau, Helen M. https://orcid.org/0000-0001-6503-5480
Funding for this research was provided by:
GlaxoSmithKline
Damon Runyon Cancer Research Foundation (DRG-2210-14)
U.S. Department of Health & Human Services | National Institutes of Health (K99NS120278)
Gouvernement du Canada | Canadian Institutes of Health Research
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (5R01GM114276)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (5U01CA199216)
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (5UL1TR00108502)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (5R01AG02096115)
Li Ka Shing Foundation
Article History
Received: 10 March 2020
Accepted: 2 March 2022
First Online: 17 March 2022
Competing interests
: J.P.K. and A.C.H. were employees of GSK during the time the work was performed. The remaining authors declare no competing interests.